CytomX Therapeutics, Inc. 4
4 · CytomX Therapeutics, Inc. · Filed Oct 16, 2015
Insider Transaction Report
Form 4
LADD CYNTHIA J
Senior VP and General Counsel
Transactions
- Award
Employee Stock Option (right to buy)
2015-07-21+246,043→ 246,043 totalExercise: $6.61Exp: 2025-07-20→ Common Stock (246,043 underlying) - Purchase
Common Stock
2015-10-14$12.00/sh+3,000$36,000→ 3,000 total - Award
Employee Stock Option (right to buy)
2015-08-26+27,393→ 27,393 totalExercise: $6.61Exp: 2025-08-25→ Common Stock (27,393 underlying)
Footnotes (2)
- [F1]This option vests 25% on June 15, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day the month, except the final installment, which shall vest on June 15, 2019.
- [F2]This option vests in 48 substantially equal monthly installments starting on August 28, 2015, with each additional installment vesting on the last day of the month.